Advertisement
Screener

ARMATA PHARMACEUTICALS, INC. (ARMP) ROE

ARMATA PHARMACEUTICALS, INC. (ARMP) ROE

  • 2026-06-30: ROE 83.13%.
  • 2026-03-31: ROE 90.70%.
  • 2025-12-31: ROE 79.51%.
  • 2025-09-30: ROE 49.07%.

Complete source-backed roe history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3083.13%
2026-03-3190.70%
2025-12-3179.51%
2025-09-3049.07%
2025-06-3036.99%
2025-03-310.79%
2024-12-3139.39%
2024-09-3081.15%
2024-06-30145.43%
2024-03-31140.82%
2023-12-31215.33%
2023-09-30480.48%
2023-06-30-193.10%
2023-03-31-189.93%
2022-12-31-102.32%
2022-09-30-71.64%
2022-06-30-55.27%
2022-03-31-42.95%
2021-12-31-91.17%
2021-09-30-99.90%
2021-06-30-84.15%
2021-03-31-66.44%
2020-12-31-117.63%
2020-09-30-81.82%
2020-06-30-71.97%
2020-03-31-62.18%
2019-12-31-133.48%
2019-09-30-88.21%
2019-06-30-52.19%
2019-03-31-272.52%
2018-12-31-132.22%
2018-09-30-129.88%
2018-06-30-81.60%
2018-03-31-86.54%
2017-12-31-52.74%
2017-09-30-204.84%
2017-06-30-218.86%
2017-03-31-285.38%
2016-12-31-193.75%
2016-09-30-63.47%
2016-06-30-17.48%
2016-03-31122.12%
2015-12-31-4.06%
2015-09-306.71%
2015-06-30128.51%
2015-03-31-647.69%
2014-12-31672.36%
2014-09-30154.54%
2014-06-30527.49%
2014-03-31273.35%
2013-12-31285.45%

Annual ROE

DateROE
2025-12-3179.51%
2024-12-3139.39%
2023-12-31215.33%
2022-12-31-102.32%
2021-12-31-91.17%
2020-12-31-117.63%
2019-12-31-133.48%
2018-12-31-217.08%
2017-12-31-52.74%
2016-12-31-193.75%
2015-12-31-4.06%
2014-12-31672.36%
2013-12-31285.45%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22